Brief: Q2 Sales Of Leqembi Bring BioArctic SEK 162.5 Mln In Royalty
July 31 (Reuters) - BioArctic AB BIOAb.ST: SALES OF LEQEMBI® TOTALED 23.1 BILLION YEN IN THE SECOND QUARTER 2025 PARTNER'S SALES RESULTS IN ROYALTY OF SEK 162.5 MILLION WHICH, UP 280% Y/Y PARTNER'S SALES EX. STOCKPILING EFFECT WERE ABOUT JPY 17.8 BILLION, CORRESPONDING TO ROYALTY OF ABOUT SEK 125 MILLION Source text: ID:nWkrxmKTp Further company coverage: [BIOAb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million